Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NSD2 | O96028 | 7/20 | 1.00 |
| ▸ | DOT1L | Q8TEK3 | 5/20 | 1.00 |
| ▸ | NNMT | P40261 | 5/20 | 1.00 |
| ▸ | CARM1 | Q86X55 | 5/20 | 1.00 |
| ▸ | SETD7 | Q8WTS6 | 4/20 | 1.00 |
| ▸ | EHMT2 | Q96KQ7 | 4/20 | 1.00 |
| ▸ | PRMT1 | Q99873 | 3/20 | 1.00 |
| ▸ | PCMT1 | P22061 | 2/20 | 1.00 |
| ▸ | SETD2 | Q9BYW2 | 2/20 | 1.00 |
| ▸ | TRDMT1 | O14717 | 2/20 | 1.00 |
| ▸ | PRMT5 | O14744 | 2/20 | 1.00 |
| ▸ | INMT | O95050 | 2/20 | 1.00 |
| ▸ | METTL3 | Q86U44 | 2/20 | 1.00 |
| ▸ | EHMT1 | Q9H9B1 | 2/20 | 1.00 |
| ▸ | METTL14 | Q9HCE5 | 2/20 | 1.00 |
| ▸ | RNMT | O43148 | 1/20 | 1.00 |
| ▸ | TPMT | P51580 | 1/20 | 1.00 |
| ▸ | NSD1 | Q96L73 | 1/20 | 1.00 |
| ▸ | NSD3 | Q9BZ95 | 1/20 | 1.00 |
| ▸ | FASN | P49327 | 3/20 | 0.75 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sinefungin SCHEMBL30779328 | 1.00 | NSD2 (1.00) | NSD2DOT1LNNMTCARM1SETD7 | |
| Sinefungin SCHEMBL19421010 | 1.00 | NSD2 (1.00) | NSD2DOT1LNNMTCARM1SETD7 | |
| Sinefungin SCHEMBL38665462 | 1.00 | NSD2 (1.00) | NSD2DOT1LNNMTCARM1SETD7 | |
| Sinefungin SCHEMBL10400321 | 1.00 | NSD2 (1.00) | NSD2DOT1LNNMTCARM1SETD7 | |
| Sinefungin SCHEMBL24478706 | 1.00 | NSD2 (1.00) | NSD2DOT1LNNMTCARM1SETD7 | |
| Sinefungin SCHEMBL14174630 | 1.00 | NSD2 (1.00) | NSD2DOT1LNNMTCARM1SETD7 | |
| Sinefungin SCHEMBL23607779 | 1.00 | NSD2 (1.00) | NSD2DOT1LNNMTCARM1SETD7 | |
| Sinefungin SCHEMBL3400839 | 1.00 | NSD2 (1.00) | NSD2DOT1LNNMTCARM1SETD7 | |
| Sinefungin SCHEMBL20992057 | 1.00 | NSD2 (1.00) | NSD2DOT1LNNMTCARM1SETD7 | |
| Sinefungin SCHEMBL19418813 | 1.00 | NSD2 (1.00) | NSD2DOT1LNNMTCARM1SETD7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2398 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12636283-B2 | Inhibition of PRC2 subunits to treat eye disorders | FONDATION ASILE DES AVEUGLES (CH) | 2026-05-26 | — | — | US | claimed |
| EP-4048260-B1 | COMBINATION OF SUBSTITUTED 4-AMINOISOINDOLINE-1,3-DIONE COMPOUNDS AND SECOND ACTIVE AGENTS FOR USE IN TREATING A HEMATOLOGICAL MALIGNANCY | CELGENE CORP (US) | 2026-03-11 | — | — | EP | claimed |
| EP-4667458-A1 | PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CANCER, COMPRISING SOS1 INHIBITOR AND ANTICANCER DRUG | Kanaph Therapeutics Inc. (KR) | 2025-12-24 | — | — | EP | claimed |
| US-20250352551-A1 | SUBSTITUTED 4-AMINOISOINDOLINE-1,3-DIONE COMPOUNDS AND SECOND ACTIVE AGENTS FOR COMBINED USE | CELGENE CORPORATION | 2025-11-20 | — | — | US | claimed |
| US-20250325717-A1 | ANTI-NUCLEOPHOSMIN 1 ANTIBODY AND ANTIBODY CONJUGATE COMBINATION THERAPIES | THE CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2025-10-23 | — | — | US | claimed |
| US-20250313647-A1 | MUTANT AND MISLOCALIZED CELL SURFACE NUCLEOPHOSMIN 1 AS A DIAGNOSTIC AND THERAPEUTIC TARGET OF HUMAN DISEASE | THE CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2025-10-09 | — | — | US | claimed |
| US-20250281468-A1 | COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY BOWEL DISEASE AND FUSOBACTERIA-CAUSED OR RELATED DISEASES AND CONDITIONS | CENTRE FOR DIGESTIVE DISEASES (AU) | 2025-09-11 | — | — | US | claimed |
| EP-3600303-B1 | A COMPOSITION COMPRISING A RIFAXIMIN AND A COMBINATION OF A VANCOMYCIN, A METRONIDAZOLE, AND/OR A TINIDAZOLE FOR TREATING AUTISM | BORODY THOMAS J (AU) | 2025-07-23 | — | — | EP | claimed |
| EP-4580677-A2 | SARS-COV2 ANTIBODIES AND USES THEREOF | Invivyd, Inc. (US) | 2025-07-09 | — | — | EP | claimed |
| US-20250144056-A1 | ANTIMICROBIAL HOST DEFENSE PEPTIDE-INDUCING COMPOSITIONS AND METHODS OF PRODUCTION AND USE THEREOF | BOARD OF REGENTS FOR THE OKLAHOMA AGRICULTURAL AND MECH COLLEGES (US) | 2025-05-08 | — | — | US | claimed |
| US-5925551-A | MUTANT ASPERGILLUS TERREUS STRAIN; FOR HIGH PRODUCTION OF MEVINOLINIC ACID, A CHEMICAL INTERMEDIATE OF LOVASTATIN; BY-PRODUCT INHIBITION; USING MONOSACCHARIDES LIKE GLUCOSE AND GALACTOSE AS CARBON SOURCE DURING FERMENTATION | CHONG KUN DANG CORPORATION (KR) | 1999-07-20 | — | — | US | claimed |
| US-5872104-A | BACTERICIDES AND RESISTANT BACTERIA WITH METHYLATION INHIBITORS | ORIDIGM CORPORATION (US) | 1999-02-16 | — | — | US | claimed |
| WO-1999006531-A1 | ASPERGILLUS GENUS SHOWING RESISTANCE TO CERULENIN AND L-METHIONINE ANALOGUE AND A PROCESS FOR PREPARING MEVINOLINIC ACID THEREFROM | CHONG KUN DANG CORPORATION (KR) | 1999-02-11 | — | — | WO | claimed |
| JP-H08507533-A | — | — | 1996-08-13 | — | — | JP | claimed |
| WO-1996020010-A1 | COMBINATION FOR REDUCING ANTIMICROBIAL RESISTANCE USING A METHYLATION INHIBITOR IN COMBINATION WITH AN ANTIBIOTIC | ORIDIGM CORPORATION (US) | 1996-07-04 | — | — | WO | claimed |
| EP-0688332-A1 | NEW A83543 COMPOUNDS AND PROCESS FOR PRODUCTION THEREOF | DOWELANCO (US) | 1995-12-27 | — | — | EP | claimed |
| WO-1995019974-A2 | CALIXARENE-BASED COMPOUNDS HAVING ANTIBACTERIAL, ANTIFUNGAL, ANTICANCER-HIV ACTIVITY | HARRIS STEPHEN J (IE) | 1995-07-27 | — | — | WO | claimed |
| WO-1994020518-A1 | NEW A83543 COMPOUNDS AND PROCESS FOR PRODUCTION THEREOF | DOWELANCO (US) | 1994-09-15 | — | — | WO | claimed |
| EP-0276131-B1 | NON-NATURAL DEMETHYLAVERMECTINS AND PROCESS THEREFOR | PFIZER INC. (US) | 1993-04-07 | — | — | EP | claimed |
| EP-0276131-A2 | Non-natural demethylavermectins and process therefor | PFIZER INC. (US) | 1988-07-27 | — | — | EP | claimed |